205 related articles for article (PubMed ID: 10612669)
21. Molecular and functional interactions of cat APOBEC3 and feline foamy and immunodeficiency virus proteins: different ways to counteract host-encoded restriction.
Chareza S; Slavkovic Lukic D; Liu Y; Räthe AM; Münk C; Zabogli E; Pistello M; Löchelt M
Virology; 2012 Mar; 424(2):138-46. PubMed ID: 22265237
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the determinants of neurotropism and neurotoxicity of HFV in transgenic mice.
Tschopp RR; Brandner S; Marino S; Bothe K; Horak I; Rethwilm A; Aguzzi A
Virology; 1996 Feb; 216(2):338-46. PubMed ID: 8607263
[TBL] [Abstract][Full Text] [Related]
23. Feline foamy virus-mediated marker gene transfer: identification of essential genetic elements and influence of truncated and chimeric proteins.
Bastone P; Bravo IG; Löchelt M
Virology; 2006 Apr; 348(1):190-9. PubMed ID: 16443252
[TBL] [Abstract][Full Text] [Related]
24. Specific binding of recombinant foamy virus envelope protein to host cells correlates with susceptibility to infection.
Herchenröder O; Moosmayer D; Bock M; Pietschmann T; Rethwilm A; Bieniasz PD; McClure MO; Weis R; Schneider J
Virology; 1999 Mar; 255(2):228-36. PubMed ID: 10069948
[TBL] [Abstract][Full Text] [Related]
25. First report on the prevalence and genetic relatedness of Feline Foamy Virus (FFV) from Turkish domestic cats.
Koç BT; Oğuzoğlu TÇ
Virus Res; 2019 Dec; 274():197768. PubMed ID: 31562905
[TBL] [Abstract][Full Text] [Related]
26. Isolation of a novel subgroup B feline leukemia virus from a cat infected with FeLV-A.
Boomer S; Gasper P; Whalen LR; Overbaugh J
Virology; 1994 Nov; 204(2):805-10. PubMed ID: 7941350
[TBL] [Abstract][Full Text] [Related]
27. The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein.
Löchelt M; Romen F; Bastone P; Muckenfuss H; Kirchner N; Kim YB; Truyen U; Rösler U; Battenberg M; Saib A; Flory E; Cichutek K; Münk C
Proc Natl Acad Sci U S A; 2005 May; 102(22):7982-7. PubMed ID: 15911774
[TBL] [Abstract][Full Text] [Related]
28. Nuclear localization of the functional Bel 1 transactivator but not of the gag proteins of the feline foamy virus.
Bodem J; Zemba M; Flügel RM
Virology; 1998 Nov; 251(1):22-7. PubMed ID: 9813199
[TBL] [Abstract][Full Text] [Related]
29. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
[TBL] [Abstract][Full Text] [Related]
30. Identification of the simian foamy virus transcriptional transactivator gene (taf).
Mergia A; Shaw KE; Pratt-Lowe E; Barry PA; Luciw PA
J Virol; 1991 Jun; 65(6):2903-9. PubMed ID: 1851862
[TBL] [Abstract][Full Text] [Related]
31. Genetic analyses of feline foamy virus isolates from domestic and wild feline species in geographically distinct areas.
Phung HT; Ikeda Y; Miyazawa T; Nakamura K; Mochizuki M; Izumiya Y; Sato E; Nishimura Y; Tohya Y; Takahashi E; Mikami T
Virus Res; 2001 Aug; 76(2):171-81. PubMed ID: 11410316
[TBL] [Abstract][Full Text] [Related]
32. Importance of the major splice donor and redefinition of cis-acting sequences of gutless feline foamy virus vectors.
Liu W; Backes P; Löchelt M
Virology; 2009 Nov; 394(2):208-17. PubMed ID: 19775717
[TBL] [Abstract][Full Text] [Related]
33. Serological detection systems for identification of cows shedding bovine foamy virus via milk.
Romen F; Backes P; Materniak M; Sting R; Vahlenkamp TW; Riebe R; Pawlita M; Kuzmak J; Löchelt M
Virology; 2007 Jul; 364(1):123-31. PubMed ID: 17408715
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the neutralization determinants of equine arteritis virus using recombinant chimeric viruses and site-specific mutagenesis of an infectious cDNA clone.
Balasuriya UB; Dobbe JC; Heidner HW; Smalley VL; Navarrette A; Snijder EJ; MacLachlan NJ
Virology; 2004 Apr; 321(2):235-46. PubMed ID: 15051384
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the internal promoter of simian foamy viruses.
Campbell M; Renshaw-Gegg L; Renne R; Luciw PA
J Virol; 1994 Aug; 68(8):4811-20. PubMed ID: 8035481
[TBL] [Abstract][Full Text] [Related]
36. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
[TBL] [Abstract][Full Text] [Related]
37. Molecular subtyping of feline immunodeficiency virus from cats in Melbourne.
Iwata D; Holloway SA
Aust Vet J; 2008 Oct; 86(10):385-9. PubMed ID: 18826508
[TBL] [Abstract][Full Text] [Related]
38. Quantification of endogenous and exogenous feline leukemia virus sequences by real-time PCR assays.
Tandon R; Cattori V; Willi B; Lutz H; Hofmann-Lehmann R
Vet Immunol Immunopathol; 2008 May; 123(1-2):129-33. PubMed ID: 18295344
[TBL] [Abstract][Full Text] [Related]
39. Analysis of west African hunters for foamy virus infections.
Goepfert PA; Ritter GD; Peng X; Gbakima AA; Zhang Y; Mulligan MJ
AIDS Res Hum Retroviruses; 1996 Dec; 12(18):1725-30. PubMed ID: 8959250
[TBL] [Abstract][Full Text] [Related]
40. Kinetics and characteristics of replication-competent revertants derived from self-inactivating foamy virus vectors.
Bastone P; Löchelt M
Gene Ther; 2004 Mar; 11(5):465-73. PubMed ID: 14973540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
